S4S (UK) Limited announces the Signing of a Letter of Intent With Therapeutic Solutions International, Inc for Distribution Rights to Patented and FDA Cleared Sleep Appliance known in the UK as SleepwellTM.
The signing of a Letter of Intent with S4S (UK) Limited gives exclusive distribution rights to Therapeutic Solutions inc for the United States to market U.S. Patented and FDA cleared titratable sleep appliance - Sleepwell (MDSA). "This letter of intent with TSI is one more forward step in our ever growing relationship," said Matt Everatt, Technical Director of S4S (UK) Limited, adding "we are very excited about TSI exclusively distributing our sleep appliance hardware in the U.S. and look forward to completing a definitive agreement. We believe that TSI with the backing of the Dr Glassman - a leading authority in Dental Sleep Medicine will achieve great success with Sleepwell. The Sleepwell has given our UK patients great success with Snoring and Sleep Apnoea Therapy for almost a decade."
Dr. Barry Glassman, VP of Education and Training, stated, "TSI's finalizing plans to enter the dental sleep market is exciting and totally consistent with our mission statement. By acquiring rights to this sleep appliance hardware, TSI enters the dental sleep market with an evidenced based technology that is competitively priced in a price sensitive market. I look forward to continuing teaching dental sleep concepts and the advantage both nationally and internationally to this appliance."
"Our alliance with S4S has provided us an opportunity to introduce a new product into the US marketplace," said Tim Dixon, CEO of TSI. Mr. Dixon added, "We have been working on this collaboration with S4S and look forward to a long and rewarding relationship. According to the American Academy of Dental Sleep Medicine 'More than 18 million Americans have sleep apnea, and many are not receiving treatment.' We intend to play a role in the treated and untreated with our Sleep Appliance hardware."
Oral appliances (also known as Mandibular Advancement Splints) are a front-line treatment for snoring and mild to moderate obstructive sleep apnoea. These small plastic devices fit in the mouth during sleep like a sports mouth guard or orthodontic retainer. Oral appliances help keep the airway open during sleep promoting adequate air intake. Oral appliances may be used alone or in combination with other treatments for sleep-related breathing disorders, such as weight management, surgery or CPAP. Therapeutic Solutions International is also a global manufacturer of the chairside anterior midpoint stop appliance (AMPSA) devices marketed internationally under the trade names Migran-X® and AMPSA CS® (known in the UK as SCi® and SCi plus®), which have helped countless patients prevent debilitating migraine and tension headache pain, bruxism, clenching, grinding, and TMJ disorders. The Migran-X® and AMPSA CS® devices are the most effective non-drug US FDA cleared dental method of migraine prevention on the market today.